These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 33268471

  • 1. Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson's disease: a cross-sectional study.
    Kazmi H, Walker Z, Booij J, Khan F, Shah S, Sudre CH, Buckman JEJ, Schrag AE.
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):158-164. PubMed ID: 33268471
    [Abstract] [Full Text] [Related]

  • 2. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K, PPMI Investigators.
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [Abstract] [Full Text] [Related]

  • 3. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [Abstract] [Full Text] [Related]

  • 4. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study.
    Joling M, Vriend C, Raijmakers PGHM, van der Zande JJ, Lemstra AW, Berendse HW, Booij J, van den Heuvel OA.
    Neuroimage Clin; 2019 Oct; 22():101755. PubMed ID: 30884365
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.
    Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, Duda JE, Facheris M, Fernández-Santiago R, Marek K, Lomeña F, Marras C, Mondragon E, Saunders-Pullman R, Waro B, LRRK2 Cohort Consortium.
    Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [Abstract] [Full Text] [Related]

  • 10. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [Abstract] [Full Text] [Related]

  • 11. Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies.
    Joling M, Vriend C, van der Zande JJ, Lemstra AW, van den Heuvel OA, Booij J, Berendse HW.
    Neuroimage Clin; 2018 Feb; 19():130-136. PubMed ID: 30035010
    [Abstract] [Full Text] [Related]

  • 12. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.
    Ransmayr G, Seppi K, Donnemiller E, Luginger E, Marksteiner J, Riccabona G, Poewe W, Wenning GK.
    Eur J Nucl Med; 2001 Oct; 28(10):1523-8. PubMed ID: 11685496
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study.
    Palermo G, Giannoni S, Frosini D, Morganti R, Volterrani D, Bonuccelli U, Pavese N, Ceravolo R.
    Mov Disord; 2020 Jun; 35(6):1028-1036. PubMed ID: 32154947
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.
    Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, Barone P, Pellecchia MT.
    Parkinsonism Relat Disord; 2017 Apr; 37():106-110. PubMed ID: 28214265
    [Abstract] [Full Text] [Related]

  • 20. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y, Yabe I, Yaguchi H, Sato C, Takei T, Terae S, Tajima Y.
    Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.